Neurology:小儿卒中年龄是远期认知预后关键,幼年卒中(29天-6岁)影响极大

2022-01-06 Naomi MedSci原创

儿童缺血性卒中是一种罕见的事件,但伴随着认知和神经后遗症风险的增加。卒中年龄是卒中预后的一个重要因素,并影响长期认知结果,与病变大小和病变位置无关。儿童早期卒中后,儿童长期认知功能改变的风险极大

     儿童动脉缺血性卒中是一种罕见的事件,但伴随着认知和神经后遗症风险的增加。多年来,与不良预后相关的因素的识别一直是研究的重点;然而,关于预后预测的研究仍然不足。

     由于在此期间快速的突触发生以及神经元网络髓鞘形成和重组过程的增加,建议发育中的大脑在早期脑损伤后更灵活,恢复能力更好。另一方面,发育中的大脑特别容易受到早期的脑损伤,导致大脑发育中断。鉴于可塑性和易损性这两种相互矛盾的观点,关于年龄对儿童中风影响的研究结果仍不清楚,一些研究还没有明确的结论。由于在这一时期快速的突触发生以及神经元网络的髓鞘形成和重组过程,发育中的大脑在早期脑损伤后的恢复能力更强。另一方面,发育中的大脑特别容易受到早期的脑损伤,导致大脑发育中断。

     虽然有几项研究检测了急性期直到卒中后两年的认知结果,但研究调查慢性晚期(卒中后>2年)患者的结果是有限的。关注慢性晚期的患者是至关重要的,因为随着时间的推移,缺陷可能会出现并增加康复过程可能远远超过中风后的最初几个月。此外,脑损伤时的发展阶段可以调节认知结果。认知发展的关键时期内的脑侮辱可能导致比认知功能出现之前或之后发生的脑损伤更差的认知结果。此外,认知功能,特别是执行功能,与生活质量、学业成就、社交能力,这强调了监测卒中后认知结果的重要性。近日,有研究学者检查了慢性期(卒中后2年以上)儿童卒中后的长期认知结果,并调查年龄是否在卒中对认知的影响,以确定认知结果较差的患者的风险。

      这项横断面研究包括先前诊断为新生儿或儿童动脉缺血性中风的中风慢性期患者(中风后2年以上)和对照组。患有活动性癫痫、严重学习困难或行为问题阻碍认知评估的参与者被排除在外。通过神经心理学测试评估了几个认知领域,包括智力、执行功能(工作记忆、抑制和认知灵活性)、处理速度、记忆、字母流畅性和视觉运动技能。对新生儿卒中(出生0至28天的中风)、儿童早期卒中(卒中29天至<6岁)和儿童晚期卒中(≥6至<16岁的中风)患者的认知长期结果进行比较。

  • 52例新生儿或儿童动脉缺血性卒中患者(中位年龄:15.3岁,IQR=10.6~18.7)和49例健康对照组(中位年龄:13.6岁,IQR=9.8~17.2)符合纳入标准。
  • 与对照组相比,儿童卒中组的认知结果明显更差。
  • 中风时年龄(与病灶大小和部位无关)对认知灵活性、处理速度和语言学习的非线性影响在早期儿童卒中(29天至<6岁)中显示出显著的意义。与新生儿、儿童晚期卒中相比,认知结果更差(p<0.05,FDR已更正)。

      卒中年龄是卒中后恢复的一个重要因素,并影响长期认知结果,与病变大小和病变位置无关。儿童早期发生卒中,长期认知功能改变的风险极大。

文献来源:Abgottspon S, Thaqi Q, Steiner L, et al. Impact of Age at Pediatric Stroke on Long-term Cognitive Outcome [published online ahead of print, 2021 Dec 16]. Neurology. 2021;10.1212/WNL.0000000000013207. doi:10.1212/WNL.0000000000013207

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-10-16 ms1000000171674034

    好文章,前几天刚遇到一例患者

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-05-13 973770871

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-03-15 MOMOlew

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-07-15 yinhl1978
  5. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-21 yx1156

    好文章啊!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-20 兰亭序123

    感谢分享,学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-20 ms8000000098130167

    非常不错

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-19 耿仁政

    小儿卒中的发病

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-19 燕子漫飞

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2094116, encodeId=1a002094116f8, content=好文章,前几天刚遇到一例患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7afa8372942, createdName=ms1000000171674034, createdTime=Sun Oct 16 22:07:03 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219355, encodeId=491412193553e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d3076338, createdName=973770871, createdTime=Fri May 13 14:54:09 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202925, encodeId=f21a120292500, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Tue Mar 15 22:50:30 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001671, encodeId=65db20016e1bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 15 17:09:23 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186675, encodeId=71a711866e56c, content=好文章啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58001397990, createdName=yx1156, createdTime=Fri Jan 21 07:28:58 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186588, encodeId=044111865883c, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83er6Gnp47UKDBUh7BiadBKe2SjdBiaibNuYmwTGkrrE34N3iaoneZnFibSziaXicAMbqIkTod8ibbI9nTwOB7w/0, createdBy=9fa32173975, createdName=兰亭序123, createdTime=Thu Jan 20 21:00:24 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186246, encodeId=17151186246c5, content=非常不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5e6474482, createdName=ms8000000098130167, createdTime=Thu Jan 20 01:08:45 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186183, encodeId=4332118618365, content=小儿卒中的发病, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93845483109, createdName=耿仁政, createdTime=Wed Jan 19 22:13:23 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186177, encodeId=78ac11861e7f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2be06161740, createdName=燕子漫飞, createdTime=Wed Jan 19 21:44:36 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186108, encodeId=b832118610843, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jan 19 18:47:34 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-19 医鸣惊人

    认真学习了

    0

相关资讯

Stroke:TMAO水平与缺血性卒中复发相关(CNSR-III研究)

王拥军教授团队利用第三次中国国家卒中登记研究(Third China National Stroke Registry, CNSR-III)队列,探讨了不同病因亚型下血浆氧化三甲胺与缺血性卒中复发之间

Stroke:卒中血管内治疗后第一个6小时的血压目标

在卒中后第一个24 h,血压通常会升高,即使经过血管内治疗(EVT)后也是如此,并且需要几天时间才能恢复到基线水平。已经证明,入院血压与EVT后的功能结局密切相关。由于血压是影响脑灌注的一个重要因素,

Stroke:缺血性卒中后静脉溶栓与降低痴呆发生率的关系

首次缺血性卒中后溶栓治疗与痴呆发生率降低独立相关。在评估缺血性卒中患者溶栓的风险/益处时,应将事件性痴呆视为相关结局。

Neurology:卒中相关性血脑屏障渗漏一例

FLAIR序列上与卒中相关的蛛网膜下腔和眼部钆渗漏可能代表了血脑/眼屏障破坏。早期的一份报告描述了卒中后>1个月进行的MRI可见到PVS钆渗漏。类淋巴系统(glymphatic)(在脑脊液-间质液交换

磁共振液体衰减反转恢复序列高信号血管征在急性缺血性卒中诊疗中的应用价值

磁共振液体衰减反转恢复序列高信号血管征在急性缺血性卒中诊疗中的应用价值

拓展阅读

【论著】基于基因表达综合数据库的缺血性卒中缺氧相关差异基因表达分析

通过生物信息学挖掘,本研究获得了10个缺血性卒中与缺氧相关的关键基因,可能为后续研究工作及诊断治疗提供了潜在靶点。

【论著】发病时间大于24小时急性后循环缺血性卒中血管内治疗的安全性与有效性分析

经过严格影像学筛选的发病时间> 24 h的急性后循环缺血性卒中患者行EVT的安全性和有效性与发病时间24 h内患者相似。

【综述】程序性坏死在缺血性卒中中的研究进展

目前国内外关于程序性坏死与缺血性卒中关系的综述较少,现就程序性坏死的特征及其在缺血性卒中中的作用进行综述。

中国成年人颈动脉粥样硬化的全国和省级水平患病率以及危险因素的研究

这项研究结果为中国制定CAS预防和管理政策以及识别高危人群提供了证据。

好文推荐 | 外泌体在缺血性卒中诊断及治疗中的研究与应用

本文主要介绍外泌体对IS的诊断价值、治疗价值以及作为药物载体的价值,为IS的治疗和科学研究提供参考。

Stroke:防治卒中及后遗症,与肠道微生物相关?

人体肠道菌群在卒中(俗称“中风”)的病理生理进展中同样发挥了关键作用,未来以肠道益生菌为基础的新型疗法有望改善卒中患者的临床结局。

2024 ESO指南:脑小血管病—第2部分:腔隙性缺血性卒中

欧洲卒中组织(ESO,European Stroke Organisation) · 2024-02-22

心房颤动的卒中预防(第1部分)

暂未更新 · 2022-11-01